Literature DB >> 6804577

Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin.

M L Edwards, J M Goodrich, D Muller, A Pollack, J E Ziegler, D W Smith.   

Abstract

The protective efficacies of bacille Calmette-Guérin (BCG) and Mycobacterium avium-intracellulare (MAI) were examined in guinea pigs that were infected by the respiratory route with one of three strains of Mycobacterium tuberculosis: two strains obtained as recent sputum isolates from an ongoing BCG trial in south India and laboratory strain H37Rv. Groups of animals were given all combinations of two treatments with BCG, MAI, or placebo and than challenged. The numbers of tubercle bacilli recovered from the primary lung lesions, primary lesion-free lung lobes, and spleens were used to estimate the relative protective effects of the various treatments. In general, BCG and MAI protected equally well against the low-virulence strain of M. tuberculosis. For the two more virulent strains the results were less clear; however, a substantial protective effect of MAI compared with BCG was noted. Infection with MAI did not significantly alter the capacity of BCG to protect against tuberculous infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804577     DOI: 10.1093/infdis/145.2.733

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania.

Authors:  Timothy Lahey; Robert D Arbeit; Muhammad Bakari; C Robert Horsburgh; Mecky Matee; Richard Waddell; Lillian Mtei; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

Review 2.  Immunity to tuberculosis from the perspective of pathogenesis.

Authors:  E Wiegeshaus; V Balasubramanian; D W Smith
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  Isolation and Identification of Environmental Mycobacteria in the Mycobacterium bovis BCG Trial Area of South India.

Authors:  T Kamala; C N Paramasivan; D Herbert; P Venkatesan; R Prabhakar
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

Review 4.  Genetic vaccination against tuberculosis.

Authors:  D B Lowrie; C L Silva; R E Tascon
Journal:  Springer Semin Immunopathol       Date:  1997

Review 5.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors.

Authors:  G A Rook; J Steele; S Barnass; J Mace; J L Stanford
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

7.  Isolation, PCR based identification, and sensitivity pattern of environmental mycobacteria from leprosy and tuberculosis patients.

Authors:  D Saravanakumar; N Elangeswaran; S Senthilkumar; G Vanaja; S Kamakshiammal; C Chandrasekar; C N Deivanayagam; M Sritharan; V Sritharan
Journal:  Indian J Clin Biochem       Date:  2000-07

8.  Exposure to Mycobacterium avium induces low-level protection from Mycobacterium bovis infection but compromises diagnosis of disease in cattle.

Authors:  J C Hope; M L Thom; B Villarreal-Ramos; H M Vordermeier; R G Hewinson; C J Howard
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 9.  Progress in the immunology of the mycobacterioses.

Authors:  G A Rook
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

10.  Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria.

Authors:  I M Orme; F M Collins
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.